Skip to content
Open access

Integrative network pharmacology and molecular modeling approaches reveal the therapeutic potential of Syzygium samarangense phytocompounds against diabetes retinopathy

Aug 2026 · Frontiers in Bioinformatics · Vol 6 · 0 citations · 60 references
Medicine

TL;DR

These multi-target interactions suggest that S. samarangense phytochemicals can modulate key DR-associated pathways, and exhibits promising multi-target activity against Diabetes retinopathy.

Abstract

Introduction Diabetes retinopathy (DR) is a progressive microvascular complication of diabetes mellitus characterized by oxidative stress, inflammation, and neurovascular dysfunction. Current therapies provide limited efficacy, highlighting the need for multi-targeted, natural therapeutic alternatives. Syzygium samarangense (SS) is a phytochemical-rich medicinal plant with potential anti-Diabetes properties. Methodology A data-driven systems pharmacology approach was employed to explore the anti-DR potential of S. samarangense phytochemicals. Twenty-nine active compounds were screened for drug-likeness using Lipinski’s Rule of Five. Overlapping targets between SS and DR were identified, yielding 403 shared targets. Network pharmacology analysis highlighted ten core proteins, including SRC, ALB, GAPDH, and TNF. Gene Ontology (GO) and KEGG pathway enrichment analyses identified key pathways such as AGE-RAGE and HIF-1 signaling. Molecular docking was performed to evaluate ligand–target interactions, followed by 500 ns molecular dynamics (MD) simulations and MM-GBSA binding free energy analysis for validation. Results and Discussion Docking studies identified Pinocembrin (SS5) and Stercurensin (SS4) as top-ranked ligands, with strong binding affinities toward SRC and ALB, respectively. MD simulations demonstrated superior structural stability for the SS5–SRC complex, whereas SS4–ALB exhibited moderate stability. MM-GBSA calculations further confirmed favorable binding energies, supporting their drug-like behavior. These multi-target interactions suggest that S. samarangense phytochemicals can modulate key DR-associated pathways. Conclusion S. samarangense exhibits promising multi-target activity against Diabetes retinopathy. Pinocembrin (SS5) and Stercurensin (SS4) emerge as potential lead compounds for further experimental validation and drug development.

Read PDF

Similar papers

Open access Aug 2026

INTEGRATED NETWORK PHARMACOLOGY, MOLECULAR DOCKING, AND IN-VITRO VALIDATION REVEAL POTENTIAL NOOTROPIC PHYTOCONSTITUENTS FROM SELECTED INDIAN MEDICINAL PLANTS AGAINST COGNITIVE IMPAIRMENT

Evaluated phytoconstituents from Allium cepa, Curcuma longa, and Coleus forskohlii suggest that curcumin, quercetin, and rosmarinic acid are promising multi-target nootropic phytoconstituents with therapeutic potential for the treatment of cognitive impairment.

M. Manke, O. Bhusnure · 0 citations
Sep 2026

Integrated network pharmacology and metabolomics reveal the mechanisms of Compound Nanxing Zhitong Plaster in anti-rheumatoid arthritis.

CNZP exhibits significant therapeutic effects on RA, potentially by downregulating NOS1 expression and subsequently correcting the metabolic imbalance of L-arginine, and this preclinical study provides mechanistic evidence for the anti-RA effect of CNZP.

Zhi-Qiang Li, Liang Cao, Jia-Jia Wang et al. · 0 citations
Open access Jul 2026

In Silico Evaluation of Dichrostachys cinerea Phytochemicals Against Alzheimer’s Disease: Network Pharmacology and Molecular Dynamics Insights

This study provides the first systems-level computational evidence for D. cinerea’s multi-target therapeutic potential in AD, establishing a molecular foundation for future experimental validation.

Prabhakar Vengadasamy, A. Vijayalakshmi · 0 citations
Aug 2026

Elucidating the Therapeutic Mechanism of Puhuaiyin in Rosacea: An Integrated Study Based on Network Pharmacology, Bioinformatics, Molecular Docking, and Molecular Dynamics Simulations.

BACKGROUND Rosacea is a chronic inflammatory skin disorder with limited therapeutic options. Puhuaiyin (PHY), a traditional Chinese medicinal formula, shows clinical efficacy, but its multi-component mechanisms remain unclear. METHODS Chemical constituents of PHY were identified by UPLC-Q-TOF-MS. Network pharmacology...

Dan Sun, Na-Na Yang, Yi-Ding Zhao et al. · 0 citations
Jul 2026

Integrated Network Pharmacology and Experimental Study: Bioactive Compounds and Mechanisms of XuanTong BuLuo Decoction in Treating Diabetic Cardiomyopathy.

It is demonstrated that XTBLD exerts cardioprotective effects against DCM via regulating its key active components, core targets (CDKN1A, IGFBP3), and related signaling pathways, providing a scientific basis for XTBLD's clinical application in DCM management.

Min Wang, Kaijie Xie, Hao Liu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.